Sulfanilamide was first recommended to the medical profession as a therapeutic agent in infections due to Streptococcus haemolyticus of the beta type. Its use has, however, widened materially from that concept. Reports from hospitals and in the general literature indicate how extensive its use has become. They warn too that such therapy is not without danger and that caution and attention to the blood picture during the administration of the drug are most necessary. Unquestionably it is a valuable therapeutic agent, yet much remains to be learned regarding its use in ophthalmic infections.
Reports in this connection are desired, that the value of the drug may be properly estimated, and for this reason the following report of a case of gonorrheal ophthalmia is submitted. It is fully realized that what has taken place in one case may give little real indication, but taken with the results in other cases it
McKee SH. GONORRHEAL OPHTHALMIA CURED AFTER ONE WEEK'S TREATMENT WITH SULFANILAMIDE. Arch Ophthalmol. 1939;21(6):1035–1036. doi:10.1001/archopht.1939.00860060145013
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.